Novozymes (NVZMY)
(Delayed Data from OTC)
$61.67 USD
-0.68 (-1.08%)
Updated Sep 19, 2025 03:59 PM ET
4-Sell of 5 4
D Value C Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVZMY 61.67 -0.68(-1.08%)
Will NVZMY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NVZMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVZMY
Is Harmony Gold (HMY) Outperforming Other Basic Materials Stocks This Year?
Has Harmony Gold (HMY) Outpaced Other Basic Materials Stocks This Year?
NVZMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Novozymes (NVZMY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Are Basic Materials Stocks Lagging Iamgold (IAG) This Year?
Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year?
Other News for NVZMY
Kepler Capital Reaffirms Their Hold Rating on Novonesis (0Q4U)
Novonesis A/S – Adr Reports Strong 2025 Earnings
Novonesis price target lowered to DKK 512 from DKK 545 at JPMorgan
Novonesis price target lowered by DKK 33 at JPMorgan
Kepler Capital Remains a Hold on Novonesis (0Q4U)